Package Leaflet: Information for the User
Midazolam Accord 5 mg/ml Solution for Injection and InfusionEFG
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
Contents of the pack
Midazolam solution for injection and infusion contains midazolam which belongs to a group of medicines known as benzodiazepines.
This is a short-acting medicine used to induce sedation (a state of calm, drowsiness or sleep) and relieve anxiety and muscle tension.
This medicine is used for:
Do not use Midazolam Accord
Do not receive midazolam if any of the above applies to you. If you are not sure, talk to your doctor or nurse before you are given this medicine.
Warnings and precautions
Adults
Before receiving midazolam, tell your doctor or nurse if you:
Children and babies
If your child is going to receive this medicine:
Talk to the doctor or nurse if any of the above applies to your child.
Using midazolam with other medicines
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription and herbal medicines.
This is especially important because taking more than one medicine at the same time can increase or decrease the effect of the medicines in question.
In particular, tell your doctor or nurse if you are taking any of the following medicines:
If you are in any of these cases (or have doubts), consult your doctor or nurse before starting to use Midazolam Accord.
Surgery
If you are going to receive an anesthetic for an operation or for dental treatment (including inhaled anesthetics that you inhale), it is important that you tell your doctor or dentist that you have been using midazolam.
Midazolam Accord with alcohol
Do not drink alcohol if you have been given midazolam. This is because alcohol can increase the sedative effect of midazolam and can cause breathing problems.
Pregnancy and breastfeeding
Tell your doctor if you are pregnant, think you may be pregnant or plan to become pregnant. Your doctor will decide if this medicine is suitable for you.
Midazolam can harm the fetus if given at the beginning of pregnancy. When high doses are given during the last stage of pregnancy, childbirth or cesarean section, there may be a risk of inhalation and your baby may have irregular heartbeats, low muscle tone (hypotonia), difficulty feeding, low body temperature, and difficulty breathing. With prolonged administration during the end of pregnancy, your baby may develop physical dependence and risk of withdrawal symptoms after birth.
Driving and using machines
This medicine can cause drowsiness, dizziness, memory loss, or affect your concentration and coordination. This can reduce your performance in tasks that require a specific skill, for example, driving or operating machines. Do not drive a vehicle or operate a machine until you have fully recovered. Your doctor will tell you when you can resume these activities.
Talk to your doctor or pharmacist if you are not sure if it is safe for you to drive while taking this medicine.
Lack of sleep or alcohol consumption can further affect your alertness.
You should always be taken home by a responsible adult after your treatment.
Midazolam Accord contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per ampoule, i.e., it is essentially "sodium-free".
Midazolam should only be given by healthcare professionals with experience (doctor or nurse). It should be given in a place (hospital, clinic or operating room) equipped to monitor and maintain the patient's breathing, heart, and circulation (cardiovascular function) and recognize the signs and control the expected side effects of anesthesia.
How much midazolam will be given
Your doctor will decide on a suitable dose for you. The dose you are given will depend on why you are being treated and the type of sedation needed. Your weight, age, state of health, how you respond to midazolam, and whether you need other medicines at the same time will also influence the dose you are given.
If you need strong painkillers, these will be given to you first and then midazolam will be given to you. Your doctor will decide on a suitable dose for you.
How midazolam will be given
Midazolam can be given to you in four different ways:
You should always be taken home by a responsible adult after your treatment.
Children and babies
If you are given too much Midazolam Accord
Your medicine will be given to you by a doctor or nurse.
If you are accidentally given too much midazolam, you may:
Stopping treatment with midazolam
If you receive long-term treatment with midazolam (you are given the medicine for a long time), you may:
Become tolerant to midazolam. The medicine becomes less effective and does not work as well for you.
Become dependent on this medicine and have withdrawal symptoms (see below).
Your doctor will gradually reduce your dose to avoid these effects.
The following effects have been seen with the use of midazolam, particularly in children and elderly patients: restlessness, agitation, irritability, involuntary movements, hyperactivity, nervousness, hostility, delirium, anger, aggression, anxiety, nightmares, hallucinations (seeing and possibly hearing things that are not really there), psychosis (loss of contact with reality), and inappropriate behavior, excitement, and seizures (these reactions are also known as paradoxical reactions, which are opposite results to the expected effects of the medicine). If you experience these, your doctor will consider stopping treatment with midazolam.
Withdrawal symptoms:
Benzodiazepine medicines, such as midazolam, can make you dependent if used for a long time (for example, in intensive care). This means that if you stop treatment suddenly or reduce the dose too quickly, you may have withdrawal symptoms. The symptoms can include:
In severe cases of withdrawal, the following may occur: feeling of loss of contact with reality, numbness and tingling of the limbs (e.g., hands and feet), sensitivity to light, noise, and touch.
Like all medicines, Midazolam Accord 1 mg/ml can cause side effects, although not everybody gets them. The following side effects have been seen with this medicine (frequency unknown).
Do not use midazolam and see a doctor urgently if you notice any of the following side effects. These could be life-threatening and may require urgent medical treatment:
The side effects that could be life-threatening are more common in adults over 60 years and those patients who already have breathing difficulties or heart problems, particularly if the injection is given too quickly or at a high dose.
Other possible side effects
Immune system disorders:
|
Behavioral effects:
Mental and nervous system problems:
Heart and circulation problems:
Breathing problems:
Stomach, intestine, and mouth problems:
Skin problems:
Muscle problems:
Problems at the injection site:
Injuries:
General:
Elderly patients:
It is more likely that life-threatening side effects will occur in adults over 60 years and those patients who already have breathing difficulties or heart problems, particularly when the injection is given too quickly or at a high dose.
Patient with severe kidney disease:
Patients with severe kidney disease are more likely to experience side effects.
If any of the side effects get serious or troublesome, or if you notice any side effects not mentioned in this leaflet, tell your doctor or nurse.
Reporting of side effects
If you experience any side effects, talk to your doctor or nurse, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Your doctor or pharmacist is responsible for storing midazolam. The storage details are as follows:
Composition of Midazolam Accord5 mg/ml
The active ingredient is midazolam (as midazolam hydrochloride).
Each ml of injectable solution contains 5 mg of midazolam (as midazolam hydrochloride).
Each 3 ml ampoule contains 15 mg of midazolam (as midazolam hydrochloride)
The other components are water for injectables, sodium chloride, sodium hydroxide (to adjust the pH), and concentrated hydrochloric acid (to adjust the pH).
Appearance of the Product and Package Contents
Midazolam Accord 5 mg/ml is a clear, colorless to pale yellow solution, packaged in a transparent glass ampoule.
Midazolam Accord 5 mg/ml is available in packages of 10 ampoules of 1 ml, 10 ampoules of 3 ml, 10 ampoules of 10 ml, and 1 ampoule of 10 ml.
The ampoules are available in a blister/tray package.
Marketing Authorization Holder
Accord Healthcare S.L.U.
World Trade Center
Moll de Barcelona s/n,
Edifici Est, 6ª planta
08039 Barcelona
Spain
Manufacturer
Accord Healthcare Polska Sp.z o.o.,
ul. Lutomierska 50, 95-200 Pabianice,
Poland
Date of Last Revision of this Prospectus:July 2024.
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
This information is intended only for doctors or healthcare professionals:
Preparation of the Solution for Infusion
Midazolam Accord can be diluted with a 0.9% sodium chloride solution, 5% or 10% glucose solution, Ringer's solution, or Hartmann's solution. In the case of continuous intravenous infusion, it can be diluted in the range of 0.015 to 0.15 mg per ml with one of the solutions mentioned above. These solutions remain stable for 24 hours at room temperature and for 3 days at 8°C. Midazolam Accord should not be mixed with any solution other than those listed above. In particular, midazolam should not be diluted with 6% dextran (with 0.9% sodium chloride) in glucose or mixed with an injection of an alkaline compound. Midazolam precipitates in hydrogen carbonate.
The injectable or infusion solution should be visually examined before administration. Only solutions without visible particles will be used.
Validity Period and Storage
Midazolam Accord is designed for single use.
Ampoule before opening
Store in the original packaging to protect it from light.
Ampoule after dilution
Physical-chemical stability has been demonstrated in use conditions for the dilutions for 24 hours at room temperature (15°C-25°C) or for 3 days at 8°C.
From a microbiological point of view, the product should be used immediately. If not used immediately, the storage times under use conditions and the conditions prior to use will be the responsibility of the user and will generally not exceed 24 hours at 2-8°C, unless the dilution has taken place in controlled and validated aseptic conditions.
In the case of continuous intravenous infusion, it can be diluted in the range of 0.015 to 0.15 mg per ml with one of the solutions mentioned above.
Disposal of Waste Products
Any unused medicine or waste material should be disposed of in accordance with local regulations.